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We cloned the genome RNA of the Chiba virus (ChV; Hu/NLV/Chiba 407/1987/JP) and determined its complete nucleotide
sequence. The genome is predicted to be a positive-sense, single-stranded RNA of 7697 bases, excluding a poly(A) tract.
Comparison of the nucleotide and amino acid sequences with those of other members of the species Norwalk virus (NV)
revealed that ChV belongs to genogroup I NV. The ChV genome contains three open reading frames (ORFs). A large
59-terminal ORF (ORF1) encodes a polyprotein with 1785 amino acids that are likely processed into functional proteins,
including RNA helicase, VPg, protease, and RNA-dependent RNA polymerase. ORF2 encodes the capsid protein with 544
amino acids, and a small 39-terminal ORF (ORF3) encodes a basic protein with 208 amino acids. The amino acid sequences
of five cleavage sites in ORF1 are highly conserved compared with those of other members of NV. When expressed in
Escherichia coli, the glutathione-S-transferase (GST) fusion protein of the ChV protease connected via a short peptide
containing a human rhinovirus 3C protease cleavage site was cleaved into GST and the protease; however, this cleavage did
not occur when the Cys mutation was introduced into the putative active site of the protease. Moreover, the ChV protease
recognized and cleaved the predicted proteolytic sites between VPg and protease and between protease and RNA
polymerase. Therefore, the ChV protease expressed in E. coli retained an enzymatic activity and a substrate specificity
similar to that of the human rhinovirus 3C protease. © 2000 Academic Press
Key Words: Norwalk virus; complete genome sequence; recombinant protein; 3C-like protease; expression in E. coli.INTRODUCTION
Norwalk virus (NV) is the causative agent of nonbac-
terial acute gastroenteritis that has occurred in various
epidemiological settings, including nursing homes (Jiang
et al., 1996; Vinje and Koopmans, 1996; Vinje et al., 1997),
chools (Kobayashi et al., 1991), hospitals (Vinje et al.,
997; Stevenson et al., 1994), restaurants (Parashar et al.,
998; Fleissner et al., 1989), and cruise ships (Herwaldt
t al., 1994; Khan et al., 1994; Ho et al., 1989; Gunn et al.,
980). Transmission of NV was carried out by contami-
ated food, especially oysters (Kohn et al., 1995; Dowell
t al., 1995) and water (Beller et al., 1997; Gray et al.,
997), and by person-to-person contact (Kaplan et al.,
982). NV was recently assigned as a new species of a
enus with the temporary name “Norwalk-like viruses” in
he family Caliciviridae. NV is usually isolated from stool
pecimens of the patient with diarrheal illness and is
ften discovered in bivalves such as oysters and in
alf-cooked foods (Dowell et al., 1995; Le Guyader et al.,
996). NV forms a group of genetically and antigenically
iverse caliciviruses. NV has been observed as small,
round particles with a diameter of 38 nm on electron
microscopy, and the term used to describe NV was “small1 To whom correspondence should be addressed. Fax: 81-3-5285-
161. E-mail: someya@nih.go.jp.
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490round structured viruses” (SRSVs) (Appleton, 1987;
Iversen et al., 1987; Brugha et al., 1999).
Since the genome of Norwalk virus (NV/68), a proto-
type of NV, was sequenced in 1993 for the first time (Jiang
et al., 1990, 1993; Hardy and Estes, 1996; M87661), de-
termination of the complete nucleotide sequence of NV
has been carried out in Southampton virus (SAV) (Lamb-
den et al., 1993; L07418), BS5 strain (unpublished,
AF093797), Lordsdale virus (LV) (Dingle et al., 1995;
X86557), Camberwell virus (CWV) (Seah et al., 1999;
AF145896), and Hawaii virus (HWV) (U07611). In addition,
a number of partial genomic sequences derived from the
RNA-dependent RNA polymerase and capsid protein re-
gion of NV have been cloned, sequenced, and deposited
in databases. Members of NV share common features in
that their genomes are a positive-sense, single-stranded
RNA molecule to which a putative genome-encoded pro-
tein called VPg is linked at the 59 end of the genome
(Estes et al., 1997; Clarke et al., 1998). Extensive genetic
analyses of NV demonstrated that NV is further classified
into two subgroups, genogroup I (GI), which includes
NV/68, SAV, and BS5, and genogroup II (GII), which in-
cludes LV, CWV, and HWV (Wang et al., 1994; Green et al.,
1994; Lew et al., 1994; Liu et al., 1995). The phylogenetic
tree of published NV sequences based on part of the
RNA-dependent RNA polymerase gene demonstrated
that the GI and GII subgroups are composed of at least
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491FUNCTIONAL EXPRESSION OF 3C-LIKE PROTEASE IN E. coliseven and five genetically distinct viruses, respectively
(Vinje et al., 2000; Green et al., 2000). Recently, the Jena
train of bovine calicivirus was cloned, and the nucleo-
ide sequence indicated that it is closely related to GI NV
Liu et al., 1999a; AJ011099).
The genome of NV contains three open reading
rames (ORFs). ORF1 encodes a large polyprotein con-
aining amino acid sequence motifs observed in many
NA viruses, such as RNA helicase, 3C-like protease
nd RNA-dependent RNA polymerase, as well as VPg,
riginally described in a poliovirus (Lee et al., 1977;
ueckert and Wimmer, 1984). Protease activity is be-
ieved to be required for the maturation of functional
roteins encoded by ORF1. ORF2 is predicted to encode
he capsid protein. ORF3 encodes a small protein abun-
ant in basic amino acids. Although the precise role of
he ORF3 protein in the virus replication is unknown, it is
ikely that ORF3 protein is a minor structural protein that
nteracts with the genome RNA when the virion formation
ccurs (Dingle et al., 1995; Jiang et al., 1993; Lambden et
l., 1993; Seah et al., 1999; Glass et al., 2000).
Previous studies showed that in vitro transcription-
ranslation of a full-length clone of SAV with a T7 poly-
erase-coupled reticulocyte lysate system yielded a
00-kDa precursor protein corresponding to the ORF1
olyprotein. This large protein was cotranslationally
leaved into three major products with 113, 48, and 41
Da (Liu et al., 1996). A 3C-like protease encoded in the
13-kDa protein is likely to function in the cleavage of the
-terminal 48-kDa protein and 41-kDa putative 2C-like
rotein. A recent study demonstrated that the nonstruc-
ural precursor polyprotein of SAV is cleaved into at least
ix smaller products (Liu et al., 1999b).
In this paper, we describe the isolation of the 59 un-
ranslated region (UTR) by 59-rapid amplification of cDNA
nds (59-RACE) and amplification of the ORF1-coding
egion of Chiba virus (ChV) by reverse transcription–
FIG. 1. Genomic organization of ChV. The ChV genome is composed
encodes a polyprotein, ORF2 encodes the capsid protein, and ORF3 e
of the genome are aligned with the sequence around the start codonolymerase chain reaction (RT–PCR) to complete the
ntire nucleotide sequence. Based on the deduced
c
tmino acid sequence of ORF1 polyprotein, the ChV pro-
ease was expressed in Escherichia coli. Bacterially ex-
ressed protease showed enzymatic activity with spec-
ficity similar to that of the human rhinovirus 3C protease.
RESULTS AND DISCUSSION
equence analyses of the ChV genome
ChV was first detected in a stool specimen collected
rom a patient with gastroenteritis in an oyster-associ-
ted outbreak that occurred in December 1987 in Chiba
refecture, Japan (Kasuga et al., 1990). The 39 half of the
enome encoding ORF2, ORF3, and 39 UTR has been
loned, and the nucleotide sequence has been deter-
ined (Utagawa et al., 1994). In this experiment, we
btained 25 different clones covering the entire genome
sing RT–PCR, as described in Materials and Methods.
oreover, to confirm the 59 end sequence of the ge-
ome, 59-RACE was also performed using the genomic
NA. The determination of the ORF1 sequence allowed
s to complete the entire genome of 7697 bases, exclud-
ng the 39 poly(A) tail. The length and GC content (47.4%)
f the genome were comparable with those of other GI
V. The ChV entire genome has an approximately 70%
ucleotide identity with those of NV/68, SAV, and BS5,
hereas it has about 50% identity with those of LV, CWV,
nd HWV.
The overall genomic organization of ChV is the same
s those of known NV (Fig. 1), in which three ORFs were
dentified. The translation of ChV ORF1 was predicted to
nitiate at nucleotide position 5, the same position as in
V/68, SAV, BS5, LV, CWV, and HWV (Hardy and Estes,
996; Lambden et al., 1995 and 1994; Seah et al., 1999).
hV ORF1 encodes a nonstructural polyprotein com-
osed of 1785 amino acid residues that is highly homol-
gous to NV/68, SAV, and BS5, with about 85% amino
cid identities. Several amino acid sequence motifs are
bases, excluding the 39 poly(A) tail. Three ORFs are predicted. ORF1
a small basic protein with unknown function. The first 26 nucleotides
2, showing 88% identity.of 7697onserved in ChV ORF1, as described later. In addition,
he first 26 nucleotides at the 59 terminus of the genome
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492 SOMEYA, TAKEDA, AND MIYAMURAwere very similar to those of the 59 end of ORF2, with 23
of the nucleotides being identical, a common feature
observed in known NV (Hardy and Estes, 1996; Lambden
et al., 1995 and 1994; Seah et al., 1999). When N-terminal
amino acid sequences of ORF1 and ORF2 of NV were
compared, we found that both ORF1 and ORF2 of GI NV
started with MMMASKD, whereas those of GII NV
started with MKMASN(IS)D.
Phylogenetic trees generated for each ORF1, ORF2,
and ORF3 are depicted in Fig. 2. ChV was most closely
related to BS5 when the amino acid sequence of ORF1
was compared. The same results were essentially ob-
tained when ORF1 was separated into six putative func-
tional parts. However, ORF2 and ORF3 of ChV were most
closely related to those of SAV. Although there is no
FIG. 2. Phylogenetic trees for ORF1 (A), ORF2 (B), and ORF3 (C) from
V whose genomes are thoroughly sequenced. Analyses are based on
he UPGMA method (Sneath and Sokal, 1974). The branch length
ndicates relative evolutionary distances. The relative alignment score
s indicated at the bottom. Norwalk virus, M87661; Southampton virus,
07418; BS5 strain, AF093797; Lordsdale virus, X86557; Camberwell
irus, AF145896; Hawaii virus, U07611.direct evidence, this suggests that genetic recombina-
tion might occur among different NV, conferring geneticdiversity on NV as described previously (Jiang et al.,
1999; Vinje et al., 2000).
Putative cleavage sites of ORF1 proteins
Five proteolytic cleavage sites have been identified in
the SAV ORF1 polyprotein (Liu et al., 1999b), and the
boundary amino acid sequences of the cleavage sites
were highly conserved among the members of NV when
seven NV ORF1 sequences were aligned. As shown in
SAV, the protease encoded in ORF1 may be involved in
the cleavage of the polyprotein at Q/G in the N-terminal
protein/helicase and helicase/3A, at E/G in the 3A/VPg
and protease/polymerase, and at E/A in the VPg/pro-
tease boundaries. Therefore, ORF1 polyprotein of ChV is
also expected to be cleaved into six portions at the
conserved cleavage sites (Fig. 3A).
The first N-terminal protein was composed of 396
amino acid residues with an estimated molecular mass
of 44.6 kDa. This protein is in the equivalent region
corresponding to 2B or 2AB of the picornavirus. Although
it has 68–80% amino acid identity with other GI NV, its
function is unknown. The second polypeptide is 2C-like
RNA helicase, which is composed of 363 amino acids
with an estimated molecular mass of 39.6 kDa. The
nucleotide-binding motif GPPGIGKT is found at position
162. The ChV helicase has about 90% amino acid identity
with other GI NV, having the highest identity with the BS5
strain (94%). The third protein, corresponding to 3A-like
protein, is composed of 201 amino acids with an esti-
mated molecular mass of 21.3 kDa and has 67–77%
identity with other GI NV. The fourth protein, VPg, is
believed to bind to the 59 terminus of the genomic RNA
and be highly homologous to other GI strains (82–89%
identity). ChV VPg is rich in basic amino acids and
migrated as a 20-kDa protein in SDS–PAGE, although it is
composed of 136 amino acid residues with an estimated
molecular mass of 16.0 kDa (see Fig. 5).
The fifth protein, corresponding to 3C-like protease, is
composed of 181 amino acid residues (19.4 kDa). The
ChV protease is a serine-like protease in which the 139th
cysteine residue within the GDCG motif is predicted to
be the active site. The 30th histidine and 54th glutamate
are conserved in all NV and probably form a catalytic
triad. The 157th histidine is also conserved and is
thought to be a member of the substrate-binding pocket
(Boniotti et al., 1994). The amino acid identity is very high
(more than 90%), as high as 95% with the BS5 strain. The
C-terminal polypeptide is the 3D RNA-dependent RNA
polymerase, containing 508 amino acid residues with an
estimated molecular mass of 56.9 kDa. This protein is
highly homologous to other GI NV (89–93% amino acid
identity), and highly conserved GLPSG and YGDD motifs,
which are believed to play an important role in the
polymerase activity, are found in all NV. An endoplasmic
reticulum-targeting signal, KDEL, is also conserved in
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493FUNCTIONAL EXPRESSION OF 3C-LIKE PROTEASE IN E. colithe RNA polymerase region, although direct evidence of
the sorting has not been shown.
Functional expression of the ChV 3C-like protease in
E. coli
In order to characterize the ChV protease, we expressed
the protein in E. coli using two types of plasmids. The first,
pUC[His-Pro], was generated for the production of the ChV
protease flanked by a histidine tag (6xHis) at the N termi-
nus, and the second, pUC[GST-Pro], was generated for the
production of a GST-protease fusion protein. In both expres-
sion vectors, the fusion genes were placed under the con-
trol of the lac promoter (Fig. 3B).
E. coli BL21-CodonPlus-RIL was transformed with the
ector plasmid and grown in a rich medium. The expres-
ion was induced with isopropyl-b-D-thiogalactopyrano-
ide (IPTG) for 2 h, followed by disruption of the cells by
onication. After centrifugation, the supernatant was col-
ected, and the proteins were separated in SDS–PAGE
nd visualized with Coomassie brilliant blue (CBB) R-250
Fig. 4A). When the lysate from the pUC[His-Pro] was
nalyzed in the gel, we observed a 23-kDa band (Fig. 4A,
ane 3). Although this molecular mass was slightly higher
FIG. 3. Schematic representation of the ChV ORF1 polyprotein and
sites. Cleavage sites are predicted on the basis of studies of the South
of the amino acids. Slashes indicate the cleavage sites recognized by
indicated. (B) Construction of the expression plasmids encoding the C
protease, and the stop codon and an SphI site are introduced after the
pUC[GST-Pro] and pUC[GST2TK-Pro] encode the protease fused to GST
sequence cleaved by the human rhinovirus 3C protease, which is possi
of the human rhinovirus 3C protease site. The fusion genes are controhan that calculated from the recombinant ChV protease
ontaining a 6xHis sequence (20.7 kDa), this band was
p
fetected by anti-His antibody (Fig. 4B, lane 3) and absent
n an E. coli extract without the vector plasmid (Fig. 4A,
ane 2). Therefore, we concluded that this 23-kDa band
as the protease containing the 6xHis sequence. The
3-kDa protein was purified and used to inject rabbits to
licit the antibody against the protease. This anti-Pro
ntibody reacted with His-Pro protein (Fig. 4D, lane 3).
ecause no other His-tagged proteins were detected by
his anti-Pro antibody (data not shown), we concluded
hat the antibody reacted with the protease moiety.
When the expression was done in E. coli transformed
ith pUC[GST-Pro], two distinct bands with 26 and 22
Da were visualized (Fig. 4A, lane 5). If an intact GST-
rotease fusion protein was generated, a band with 46.5
Da was expected. The GST gene was derived from
GEX-6P-2 vector, and this GST gene contains an oc-
apeptide (LEVLFQGP) at the C terminus, in which Q/G is
he cleavage site recognized by the human rhinovirus 3C
rotease. When the specificity of the 3C-like proteases of
AV is considered (Liu et al., 1996 and 1999b), it is likely
hat the Q/G site between the GST and the ChV protease
as recognized by the protease and that the 46.5-kDa
rotein is cleaved into two proteins. Because the 26-kDa
ction of the expression plasmids. (A) Map of the proteolytic cleavage
n virus (Liu et al., 1996 and 1999). The numbers indicate the positions
tease. The calculated molecular masses of the cleavage products are
tease. An Aor51HI site is introduced before the start (APPTL) of the
TLE) of the protease. pUC[His-Pro] encodes the His-tagged protease.
d from pGEX-6P-2 and pGEX-2TK, respectively. The former includes the
ved by the ChV protease. The latter includes the thrombin site in place
the lac promoter (Plac).constru
ampto
the pro
hV pro
end (ET
deriverotein has mobility similar to that of a control GST-6xHis
usion protein (Fig. 4A, lanes 5 and 9) and has immuno-
1235A
494 SOMEYA, TAKEDA, AND MIYAMURAreactivity to anti-GST antibody (Fig. 4C, lanes 3 and 7),
this 26-kDa protein should be the GST protein. Therefore,
the 22-kDa band represents the ChV protease, because
it has a size similar to that containing the 6xHis se-
quence as described earlier (23 kDa) and it has immu-
noreactivity to anti-Pro antibody (Fig. 4D, lane 5). These
results indicate that ChV protease expressed in E. coli is
enzymatically active and capable of cleaving the specific
site recognized by the human rhinovirus 3C protease.
Identification of the functional element of the ChV
protease
FIG. 4. Expression of the fusion proteins of the ChV protease. Expres
gene expression was induced with IPTG. The cell lysates were subjecte
marker; lane 2, lysates from BL21-CodonPlus-RIL cells without plasmi
pUC[GST-Pro]; lane 6, with pUC[GST2TK-Pro]; lane 7, with pUC[GST-Pr
(B) Western blot analysis with anti-His monoclonal antibody. Lane 1, m
lane 4, with pUC[His-ProC1235A]; lane 5, with pUC[GST-His]. (C) Weste
2, without plasmids; lane 3, with pUC[GST-Pro]; lane 4, with pUC[G
ProC1235A]; lane 7, with pUC[GST-His]. (D) Western blot analysis with
marker; lane 2, without plasmids; lane 3, with pUC[His-Pro]; lane 4, wit
Pro]; lane 7, with pUC[GST-ProC1235A]; lane 8, with pUC[GST2TK-ProCAs shown previously (Liu et al., 1996 and 1999b), 3C-
like protease of SAV is thought to be a serine-like pro-tease, and the active site is predicted to be a cysteine
residue within the GDCG motif conserved in the pro-
teases. In the ChV genome, it corresponds to the 1235th
cysteine residue in the precursor polyprotein (Cys1235).
Therefore, this amino acid was replaced with alanine by
using an oligonucleotide-directed site-specific mutagen-
esis, as described under Materials and Methods. The
mutated protease gene was introduced into an expres-
sion vector in the same manner as pUC[His-Pro] and
pUC[GST-Pro] to generate pUC[His-ProC1235A] and
pUC[GST-Pro C1235A], respectively. These plasmids
were introduced into E. coli and were subjected to the
lasmids were used to transform E. coli BL21-CodonPlus-RIL cells. The
S–PAGE. (A) CBB staining of the gel. Lanes 1 and 10, molecular weight
3, with pUC[His-Pro]; lane 4, with pUC[His-ProC1235A]; lane 5, with
A]; lane 8, with pUC[GST2TK-ProC1235A]; lane 9, with pUC[GST-His].
r weight marker; lane 2, without plasmids; lane 3, with pUC[His-Pro];
analysis with anti-GST antibody. Lane 1, molecular weight marker; lane
-Pro]; lane 5, with pUC[GST-ProC1235A]; lane 6, with pUC[GST2TK-
o antibody raised against His-Pro proteins. Lane 1, molecular weight
His-ProC1235A]; lane 5, with pUC[GST-Pro]; lane 6, with pUC[GST2TK-
].sion p
d to SD
ds; lane
oC1235
olecula
rn blot
ST2TK
anti-Pr
h pUC[expression. In the extract of E. coli harboring pUC[His-
ProC1235A], a 23-kDa mutant protease band was de-
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495FUNCTIONAL EXPRESSION OF 3C-LIKE PROTEASE IN E. colitected by CBB staining of the gel (Fig. 4A, lane 4) and
Western blot analysis with anti-His antibody (Fig. 4B, lane
4) and anti-Pro antibody (Fig. 4D, lane 4). The size of the
band in the gel is identical to that of the wild-type pro-
tease (Figs. 4A, lane 3, 4B, lane 3, and 4D, lane 3). In the
extract of E. coli harboring pUC[GST-ProC1235A], a band
with an apparent mass of 44 kDa was visualized (Fig. 4A,
lane 7), and Western blot analysis indicated that this
band was reactive to anti-GST antibody (Fig. 4C, lane 5)
and anti-Pro antibody (Fig. 4D, lane 7). Although the
fusion protein contains a sequence recognized by the
human rhinovirus 3C protease, it was not cleaved by the
mutant protease at all, demonstrating that the C1235A
mutation caused a complete loss of cleaving activity. The
results confirmed the importance of Cys1235 residue as
a functional element.
To further confirm the specificity of the cleavage, we
constructed an expression vector containing the active
ChV protease designated pUC[GST2TK-Pro]. This vector
contains a GST gene derived from an expression vector
pGEX-2TK, which is flanked by a thrombin-specific cleav-
age sequence (LVPR/GS) and a kinase-specific se-
quence (RRASV) at the C terminus. However, this plas-
mid lacks the human rhinovirus 3C protease recognition
sequence. When the extract from E. coli cells harboring
this plasmid was analyzed by SDS–PAGE, a fusion pro-
tein with an apparent molecular mass of 44 kDa was
visualized, a size close to the calculated mass of 46.7
kDa (Fig. 4A, lane 6). This protein was immunoreactive to
anti-GST antibody (Fig. 4C, lane 4) and anti-Pro antibody
(Fig. 4D, lane 6). The results indicate that the fusion
protein was resistant to digestion by ChV 3C-like pro-
tease consistent with the lack of a cleavage site. A
plasmid containing the C1235A mutant protease gene
designated pUC[GST2TK-ProC1235A] resulted in the pro-
duction of a 44-kDa protein, as with the case of
pUC[GST2TK-Pro] (Figs. 4A, lane 8, 4C, lane 6, and 4D,
lane 8).
Cleavage at the predicted proteolytic sites by the ChV
protease
We were most interested to see whether the ChV
protease could cleave the predicted proteolytic sites
within the ChV ORF1 polyprotein. We therefore con-
structed two plasmids, pUC[His-3BCD] and pUC[His-
3CD], encoding the VPg (3B)-protease (3C)-RNA poly-
merase (3D) region and the protease-RNA polymerase
region, respectively, and tested whether the se-
quences between VPg and protease and between pro-
tease and RNA polymerase were cleaved by the ChV
protease in E. coli. When the lysate of E. coli cells with
pUC[His-VPg] was examined by Western blot analysis,
a 23-kDa band was detected with both anti-His anti-
body (Fig. 5A, lane 3) and anti-VPg antibody (Fig. 5B,
lane 3). Although the calculated mass of His-VPg pro-tein is 17.5 kDa, mobility in SDS–PAGE was much
slower. This is probably because VPg protein is rich in
basic amino acid residues. In the lysate of E. coli cells
carrying pUC[Pol-His], we detected a 58-kDa band that
was reactive with both anti-His antibody (Fig. 5A, lane
7) and anti-Pol peptide antibody (Fig. 5D, lane 3).
These results indicated that antibodies raised against
VPg and RNA polymerase were highly specific to the
respective proteins.
Next, using these antibodies, we examined the ex-
pression of His-3BCD and His-3CD proteins. If the His-
3BCD protein (93.7 kDa) is cleaved at the predicted
proteolytic sites, a His-VPg with 17.5 kDa, a protease with
19.4 kDa, and an RNA polymerase with 56.9 kDa are
expected to be produced. When the lysate of E. coli cells
ith pUC[His-3BCD] was separated on SDS–PAGE, a
3-kDa band was detected with both anti-His antibody
nd anti-VPg antibody (Figs. 5A, lane 4, and 5B, lane 4).
his 23-kDa band had the same mobility as the control
is-VPg protein, suggesting that the cleavage occurred
t the predicted site (FE/AP) between VPg and protease.
wo faint bands of 94 and 40 kDa, corresponding to
is-3BCD and His-3BC, respectively, were also detected
ith anti-VPg antibody (Fig. 5B, lane 4). Anti-Pro antibody
etected a 20-kDa band corresponding to protease and
77-kDa band corresponding to 3CD (Fig. 5C, lane 4),
nd anti-Pol peptide antibody detected a 57-kDa band
orresponding to RNA polymerase (Fig. 5D, lane 4).
hese results suggested that the cleavage between pro-
ease and RNA polymerase also occurred at the pre-
icted site (LE/GG).
The 20-kDa band detected with anti-Pro antibody (Fig.
C, lane 4) was subjected to the N-terminal amino acid
equencing that produced the sequence APITLASRVVR-
GSG. The amino acid sequence deduced from the nu-
leotide sequence is APPTLWSRVVRFGSG. Although the
hird and sixth amino acid residues were inconsistent, it
ay be sequencing error due to low yields of sequenc-
ng reactions at those positions, because nucleotide
equencing of pUC[His-3BCD] indicated P (proline) at
he third position and W (tryptophan) at the sixth position.
he data indicated that the cleavage between VPg and
rotease occurred exactly at the predicted site (FE/AP)
nd that the ChV protease expressed in E. coli retained
ubstrate specificity.
The His-3CD protein is expected to be cleaved into
is-Pro with 20.7 kDa and an RNA polymerase with
6.9 kDa. When the lysate of E. coli cells harboring
pUC[His-3CD] was examined by Western blot analysis,
anti-His antibody and anti-Pro antibody detected a
77-kDa band corresponding to His-3CD, as well as a
23-kDa His-Pro band corresponding to His-Pro pro-
teins (Figs. 5A, lane 6, and 5C, lane 5). Much more of
the 77-kDa protein remained uncleaved, compared
with the case of the 94-kDa His-3BCD protein (see Fig.
5B, lane 4). Anti-Pol peptide antibody detected both a
2, with
496 SOMEYA, TAKEDA, AND MIYAMURA57-kDa RNA polymerase and a 77-kDa uncut His-3CD
(Fig. 5D, lane 5). It is likely that the activity of the
protease from His-3CD was lower than that from His-
3BCD. An unnatural His-tag sequence introduced prior
to protease moiety may affect proteolytic activity. In
any case, it was clearly demonstrated that the ChV
protease recognized and cleaved the predicted pro-
teolytic site between a protease and an RNA polymer-
ase.
From these results, we concluded that the ChV 3C-like
protease expressed in E. coli had a proteolytic activity
FIG. 5. Cleavage of the predicted intrinsic sequences by the
BL21-CodonPlus-RIL cells. The gene expression was induced with
analysis with anti-His monoclonal antibody. Lane 1, molecular weigh
pUC[His-3BCD]; lane 5, with pUC[His-Pro]; lane 6, with pUC[His-3CD
raised against His-VPg proteins. Lane 1, molecular weight mark
pUC[His-3BCD]. (C) Western blot analysis with anti-Pro antibody.
pUC[His-Pro]; lane 4, with pUC[His-3BCD]; lane 5, with pUC[His
KLH-conjugate of Pol-peptide. Lane 1, molecular weight marker; lane
lane 5, with pUC[His-3CD].and retained a substrate specificity, which would be
exerted in mammalian cells. The molecules expressed inE. coli might be useful for structure–function study as
well as drug design in diarrheal therapy.
Correction of the nucleotide sequence for the ChV
ORF2
Although the sequence data for ORF2 and ORF3 of the
ChV have been registered as AB022679 and D38547, two
errors were found in ORF2. Two guanine residues at
positions 941 and 947 in the sequence from AB022679
should be replaced with cytosine. As a result, amino
protease. Expression plasmids were used to transform E. coli
. The cell lysates were subjected to SDS–PAGE. (A) Western blot
er; lane 2, without plasmids; lane 3, with pUC[His-VPg]; lane 4, with
, with pUC[Pol-His]. (B) Western blot analysis with anti-VPg antibody
e 2, without plasmids; lane 3, with pUC[His-VPg]; lane 4, with
, molecular weight marker; lane 2, without plasmids; lane 3, with
(D) Western blot analysis with anti-Pol antibody raised against
out plasmids; lane 3, with pUC[Pol-His]; lane 4, with pUC[His-3BCD];ChV
IPTG
t mark
]; lane 7
er; lan
Lane 1
-3CD].acids at positions 314 and 316 were changed to Ala in
place of Gly.
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The nucleotide sequence data reported in this paper will
appear in the DDBJ, EMBL, and GenBank nucleotide se-
quence databases with the accession number AB042808.
MATERIALS AND METHODS
Bacterial strains
E. coli strains TG1, JM109, DH5a (TaKaRa Shuzou Co.,
Tokyo, Japan), and XL10-Gold (Stratagene, La Jolla, CA)
were used for the genetic manipulation. E. coli CJ236
strain (TaKaRa Shuzou Co.) was used for the preparation
of the deoxyuracil-containing single-stranded DNA. E.
coli BL21-CodonPlus-RIL strain (Stratagene) was used
for the expression of recombinant proteins.
cDNA cloning of the ChV genome
The genomic RNA of ChV was extracted from a 10%
stool suspension by using TRIZOL LS (Life Technologies,
Grand Island, NY) according to the manufacturer’s in-
struction. First-strand cDNA was synthesized using the
RAV-2 reverse transcriptase (TaKaRa Shuzou Co.) with
random nanomer (TaKaRa Shuzou Co.) or oligo(dT)18
primer (TaKaRa Shuzou Co.) and used as a template for
the PCR. Amplification was done by using ExTaq (TaKaRa
Shuzou Co.), AmpliTaq Gold (PE Applied Biosystems,
Branchburg, NJ), or PfuTurbo (Stratagene) DNA polymer-
ase with a specific primer based on the ChV ORF2, and
degenerated primers based on the complete NV se-
quences appeared in the databases. The PCR products
were subjected to PAGE, and the separated fragment
was electrophoretically eluted from the excised gel,
which was then ligated with pCR2.1 T-vector (Invitrogen,
San Diego, CA) or pUC118 HincII/BAP vector (TaKaRa
huzou Co.). The 59 UTR of the genomic RNA was am-
plified with AmpliTaq DNA polymerase by 59 RACE using
DNA as the template. The nucleotide sequence was
etermined with the ABI Prism 310 Genetic Analyzer (PE
pplied Biosystems). Individual PCR fragments were am-
lified at least three times independently, and at least
hree clones from each PCR product were subjected to
ucleotide sequence determination. The fragment, in-
luding the 59 UTR and the entire ORF1 coding region of
hV, was reconstructed on pUC118 vector by ligating
everal restriction fragments and designated pUC-
CVORF1]. The ORF2, ORF3, and 39 UTR were amplified
ith the same strategy, cloned into pUC118 vector, and
equenced. The full-length ChV genome was recon-
tructed on pUC118, which is designated pUC[CVORF1/
/3].
onstruction of plasmids used for expression
n E. colipUC118Nd, which contains the NdeI site overlapped at
he initial codon of the lacZ gene, was constructed from
u
TUC118 by site-directed mutagenesis. Mutagenesis was
arried out according to the method described by Kunkel
t al. (1987) using the Mutan-K mutagenesis kit (TaKaRa
huzou Co.). The pUC118Nd was digested with NdeI and
indIII, and the following four 59-phosphorylated oligo-
ucleotides were inserted to construct pUCHisNd con-
aining a fragment encoding a 6xHis tag: 59-TATGGGTG-
CCATCATCATCATCACCATGGGGCTA-39, 59-GCGCTC-
CGGGAGATCTTCGAACGCGTACGCATGCA-39, 59-AGC-
TGCATGCGTACGCGTTCGAAGATCTCCCGGG-39, and
9-AGCGCTAGCCCCATGGTGATGATGATGATGGCCACC-
A-39.
The gene encoding the ChV 3C-like protease was
mplified by PCR using pUC[CVORF1] as a template and
set of primers. The forward primer (Pro-5A, 59-CTCAG-
AGCGCTGCCCCACCAACCCTCTGG-39) contains an
Aor51HI site (underlined) introduced before the GCC
codon for Ala1097, and the reverse primer (Pro-3S, 59-
TTTGCATGCTTACTCTAGGGTGGTTTCACCTTC-39) con-
tains the stop codon and an SphI site (underlined) after
the GAG codon for Glu1277. The PCR product was cloned
into pUC118 HincII/BAP vector and designated pUC-
[CVPro-AS]. The Aor51HI–SphI fragment encoding the
protease was cut out and inserted into the equivalent
position on pUCHisNd to generate pUC[His-Pro].
The gene fragment was amplified by PCR with pGEX-
6P-2 (Amersham Pharmacia Biotech, Piscataway, NJ) as
a template using the forward primer (GST-5N, 59-ACAG-
TACATATGTCCCCTATACTAG-39) containing an NdeI site
overlapping at the initial codon, as indicated by under-
lining, and the reverse primer (GST-3A, 59-AGTCGAC-
CCAGCGCTTCCTGGGGATCCC-39) containing an Aor51HI
site, as indicated by underlining. The GST gene was also
amplified by PCR with pGEX-2TK (Amersham Pharmacia
Biotech) as a template using the same forward primer
(GST-5N) and the reverse primer (2TK-3A, 59-TCAGTCACG-
GCGCTTCCCGGGGATCCAAC-39) containing an Aor51HI
site, as indicated by underlining. The PCR fragment was
cloned into pUC118 HincII/BAP vector to construct
pUC[GST6P-NA] and pUC[GST2TK-NA], and the nucleo-
tide sequence was verified. The NdeI–Aor51HI fragment
containing the GST gene was isolated from the
pUC[GST6P-NA] or pUC[GST2TK-NA] and inserted into
the NdeI–SphI site of pUC118Nd along with the Aor51HI–
phI fragment containing ChV 3C-like protease. The
lasmid carrying the GST gene derived from pGEX-6P-2
as designated pUC[GST-Pro], and the plasmid carrying
he gene from pGEX-2TK was designated pUC[GST2TK-
ro].
The mutation of Cys to Ala at position 1235 in the
rotease was introduced by a site-directed mutagenesis.
he plasmid pUC[CVPro-AS] and a synthetic oligonucle-
tide (59-CTACCAGGTGATGCCGGCGCCCCTTATGTG-39)
quivalent to the nucleotide residues 3695–3724 were
sed as a template and a mutagenic primer, respectively.
he introduction of proper mutation was monitored by
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498 SOMEYA, TAKEDA, AND MIYAMURAthe appearance of two unique restriction enzyme sites.
One is the EheI site (GGCGCC), which contains a T-to-C
silent mutation at the nucleotide position 3712, and the
other is the NaeI site (GCCGGC), which contains the
Cys-to-Ala change (TGT to GCC, represented in bold
letters). The substitutions were verified by DNA sequenc-
ing, and no other mutation was confirmed. The resultant
expression plasmid to produce mutant proteases was
designated pUC[CVPro-ASC1235A]. Plasmids pUC[His-
ProC1235A], pUC[GST-ProC1235A], and pUC[GST2TK-
ProC1235A] encoding the mutant ChV protease were
constructed by the same strategy used to construct
pUC[His-Pro], pUC[GST-Pro] and pUC[GST2TK-Pro] en-
coding the wild-type protease, respectively.
The genes encoding the VPg and the RNA-dependent
RNA polymerase were amplified by PCR using pUC-
[CVORF1] as a template. For subcloning of VPg, the
forward primer (VPg-5A, 59-ACTAGCGCTGGTAAAAA-
CAAAGGAAAGACCAAG-39) contains an Aor51HI site
(underlined) introduced prior to the GGT codon for
Gly961, and the reverse primer (VPg-3S, 59-GGTGCAT-
GCTTATTCAAAACTGAGTTTTTCATTGTA-39) contains the
stop codon and an SphI site (underlined) after the GAA
codon for Glu1096. The PCR product was cloned into
pUC118 HincII/BAP vector and designated pUC[CVVPg-
AS]. The Aor51HI–SphI fragment encoding the VPg was
cut out and inserted into the equivalent position on pU-
CHisNd to generate pUC[His-VPg]. For subcloning of
RNA polymerase, the forward primer (Pol-5N, 59-GGT-
GAAACCACCCATATGGGTGGTGATAAAGGC-39) contains
an NdeI site (underlined) introduced prior to the GGT
codon for Gly1278, and the reverse primer (Pol-3A,
59-GGTGGATCCAGCGCTGACGCCATCATCATTTACGA-
ATTC-39) contains an Aor51HI site (underlined) after the
GTC codon for Val1785, the last amino acid of the
polyprotein. The PCR product was cloned into pUC118
HincII/BAP vector and designated pUC[CVPol-NA]. The
NdeI–Aor51HI fragment encoding the RNA polymerase
was cut out and inserted into the NdeI–BamHI vector
fragment of pUC118Nd together with the His-tag linker
(the mixture of 59-GCTGGCCACCATCATCATCACCATG-
GCTAG-39 and 59-GATCCTAGCCATGGTGATGATGATG-
GTGGCCAGC-39). The resultant plasmid was designated
pUC[Pol-His].
The region encoding 3CD (protease and RNA polymer-
ase) and 3BCD (VPg, protease and RNA polymerase)
was also amplified by PCR. For amplification of the 3CD-
encoding region, the Pro-5A primer and the reverse
primer (Pol-3S, 59-GTAGCATGCTTAGACGCCATCATCATT-
TACGAATTC-39) containing a stop codon and an SphI
site after the GTC codon for Val1785 were used. For
amplification of the 3BCD-encoding region, we used the
VPg-5A primer and the Pol-3S primer. The Aor51HI–SphI
fragments from amplified products were inserted into the
equivalent position on pUCHisNd. The resultant plas-
e
wmids were designated pUC[His-3CD] and pUC[His-
3BCD], respectively.
Expression of wild-type and mutant proteases
in E. coli
E. coli BL21-CodonPlus-RIL cells were transformed
with the expression plasmids. The transformant was
grown in 23 YT broth, and protein expression was in-
duced with 0.5 mM IPTG when optical density at 610 nm
reached 0.4. After 2 h of incubation, cells were har-
vested, washed with 20 mM Tris–HCl (pH 7.4), and dis-
rupted by sonication. The cell lysate was centrifuged to
remove unbroken cells, and the supernatant was used
as a sample. The protein concentration was determined
by the Bradford method (1976) using bovine serum albu-
min as a standard. The supernatant containing 20 mg of
roteins was used for SDS–PAGE, followed by staining
ith CBB R-250 or Western blotting. The His-tagged
rotein was detected by mouse anti-His monoclonal an-
ibody (Sigma Chemical Co., St. Louis, MO) and alkaline
hosphatase-linked goat anti-mouse IgG (Jackson Im-
unoResearch Laboratories, West Grove, PA). The GST
usion was detected by goat anti-GST antibody (Amer-
ham Pharmacia Biotech) and alkaline phosphatase-
inked rabbit anti-goat IgG (Chemicon International, Te-
ecula, CA).
urification of His-Pro and His-VPg proteins
E. coli BL21-CodonPlus-RIL cells harboring pUC[His-
ro] were grown in the same manner as described ear-
ier. Cells were suspended in 20 mM Tris–HCl (pH 7.4) to
final concentration of 0.2 g cells/ml and disrupted by
onication. After removal of unbroken cells, the lysate
as centrifuged at 200,000 3 g for 1 h at 4°C, and the
upernatant was taken as the starting material for puri-
ication. The supernatant containing 100 mg of proteins
as applied to a column (bed volume, 1 ml) packed with
ALON Metal Affinity Resin (Clontech, Palo Alto, CA) that
ad been equilibrated with 20 mM Tris–HCl (pH 8.0)
uffer containing 0.1 M NaCl. The column was washed
ith 20 mM Tris–HCl (pH 8.0) buffer containing 0.1 M
aCl and 10 mM imidazole. His-Pro proteins were eluted
ith 20 mM Tris–HCl (pH 8.0) buffer containing 0.1 M
aCl and 50 mM imidazole. His-Pro proteins were puri-
ied almost to homogeneity as judged by SDS–PAGE.
urified His-Pro proteins were concentrated to 3 mg/ml
y using an Ultrafree-15 Centrifugal Filter Device
quipped with a Biomax-10 filter (Millipore, Bedford, MA).
His-VPg proteins were purified from E. coli BL21-
odonPlus-RIL cells harboring pUC[His-VPg] in the
ame manner as was used to purify His-Pro proteins,
xcept that pH 9.0 Tris buffer was used for purification
ith metal affinity chromatography.
B499FUNCTIONAL EXPRESSION OF 3C-LIKE PROTEASE IN E. coliPreparation of antisera against VPg, protease and
RNA polymerase
Antisera against VPg and protease were prepared
using purified His-VPg and His-Pro proteins, respectively.
For preparation of antiserum against RNA polymerase,
we used the conjugate of the synthetic peptide (N-
1390DKTTSSGHPYHKRKNDDWNG1409-C) and KLH (key-
hole limpet hemocyanin).
Purified His-tagged proteins (1.5 mg) or conjugate (3.3
mg) was mixed with Freund’s complete adjuvant, and
rabbits were immunized subcutaneously with each emul-
sion. At 4 weeks, the rabbits were boosted with the
mixture of respective protein and Freund’s incomplete
adjuvant. At 5 weeks, the rabbits were boosted with the
respective protein solution. At 6 weeks after initial im-
munization, we bled the rabbits to prepare antisera.
Isolation of proteins for amino acid sequencing
The lysate of E. coli BL21-CodonPlus-RIL cells harbor-
ing pUC[His-3BCD] was separated by SDS–PAGE, fol-
lowed by electroblotting onto Trans-Blot PVDF mem-
brane (Bio-Rad, Hercules, CA). The membrane was
stained by CBB R250, and then the 20-kDa band corre-
sponding to the ChV protease was excised for amino
acid sequencing (Sawady Technology, Japan).
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